Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …

Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …

Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

Background and objectives Extracorporeal photopheresis (ECP) is one of the second-line
treatment strategies in steroid-refractory acute graft-versus-host disease (aGvHD). We aimed …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …

BACKGROUND Extracorporeal photopheresis (ECP) is a recognized second‐line treatment
for steroid‐refractory chronic graft‐versus‐host disease (cGVHD). Treatment course is …

Background Extracorporeal photopheresis (ECP) is recommended as a second-or later-line
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance of …

Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …

Recently, Pidala and Anasetti [1] presented a review on glucocorticoid-refractory acute graft-
versus-host disease (aGVHD), which included options for salvage therapies and future …